Form 4 for CYTK CYTOKINETICS INC
Accepted 2023-03-07 00:00:00 ET · period of report 2023-03-06 · accession 0001127602-23-009279 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-07 | 2023-03-06 | CYTK | Blum Robert I | Pres, CEO, Dir | A - Grant | $0.00 | +82.5K | 441.1K | +23% | $0 |
| DM | 2023-03-07 | 2023-03-06 | CYTK | Blum Robert I | Pres, CEO, Dir | A - Grant | $0.00 | +165.0K | 2,555 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-06 | A | A | 82,500 | $0.00 | 441,058 | D | — | — | |
| 2 | Derivative | Non-Qualified Stock Option (Right to Buy) | 2023-03-06 | A | A | 162,445 | $0.00 | 162,445 | D | $39.13 · 2023-04-06 to 2033-03-06 | 162,445 Common Stock | |
| 3 | Derivative | Incentive Stock Option (Right to Buy) | 2023-03-06 | A | A | 2,555 | $0.00 | 2,555 | D | $39.13 · 2023-04-06 to 2033-03-06 | 2,555 Common Stock |